×
About 144,486 results

ALLMedicine™ Schizophrenia Center

Research & Reviews  68,315 results

Reduced willingness to expend effort for rewards is associated with risk for conversion...
https://doi.org/10.1017/S003329172100204X
Psychological Medicine; Strauss GP, Bartolomeo LA et. al.

Jun 14th, 2021 - Schizophrenia (SZ) is typically preceded by a prodromal (i.e. pre-illness) period characterized by attenuated positive symptoms and declining functional outcome. Negative symptoms are prominent among individuals at clinical high-risk (CHR) for psy...

A comparison of phenomenological, clinical and familial psychiatric features of pediatr...
https://doi.org/10.1080/13651501.2021.1933041
International Journal of Psychiatry in Clinical Practice; Yıldız Miniksar D, Yüksel T et. al.

Jun 14th, 2021 - Although trichotillomania (TTM) is classified in the obsessive-compulsive disorders (OCD) chapter of the DSM-5, several studies showed that it has several differences. The aim of this study was to examine the phenomenology, comorbidity, and family...

Behavioral and neurobiological changes in a novel mouse model of schizophrenia induced ...
https://doi.org/10.1016/j.brainresbull.2021.06.007
Brain Research Bulletin; Sun ZY, Gu LH et. al.

Jun 13th, 2021 - Schizophrenia is a mental illness characterized by episodes of psychosis, apathy, social withdrawal, and cognitive impairment. White matter lesions and glutamatergic hypofunction are reported to be the key pathogeneses underlying the multiple clin...

Deficits in multi-scale top-down processes distorting auditory perception in schizophre...
https://doi.org/10.1016/j.bbr.2021.113411
Behavioural Brain Research; Yang F, Zhu H et. al.

Jun 13th, 2021 - Cognitive models postulate that impaired source monitoring incorrectly weights the top-down prediction and bottom-up sensory processes and causes hallucinations. However, the underlying mechanisms of the interaction, such as whether the incorrectl...

Functional Brain Network Dysfunctions in Subjects at High-risk for Psychosis: A Meta-an...
https://doi.org/10.1016/j.neubiorev.2021.06.020
Neuroscience and Biobehavioral Reviews; Del Fabro L, Schmidt A et. al.

Jun 13th, 2021 - Although emerging evidence suggests that altered functional connectivity (FC) of large-scale neural networks is associated with disturbances in individuals at high-risk for psychosis, the findings are still far to be conclusive. We conducted a met...

see more →

Guidelines  47 results

The American Psychiatric Association Practice Guideline for the Treatment of Patients W...
https://doi.org/10.1176/appi.ajp.2020.177901
The American Journal of Psychiatry; Keepers GA, Fochtmann LJ et. al.

Sep 1st, 2020 - The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.|2020|Keepers GA,Fochtmann LJ,Anzia JM,Benjamin S,Lyness JM,|methods,methods,methods,classification,therapeutic use,diagnosis,therapy,

CAPLYTA® (lumateperone) | Now Approved | caplyta.com‎
https://www.caplyta.com/‎

Jan 13th, 2020 - Learn about a new treatment. See full safety information, PI, and boxed warning. Get information about this orally administered capsule. Press Release. Prescribing Information. MOA. Important Safety Info. Dosing & Administration.

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated r...
https://doi.org/10.1177/0269881119889296
Journal of Psychopharmacology (Oxford, England); Barnes TR, Drake R et. al.

Dec 12th, 2019 - These updated guidelines from the British Association for Psychopharmacology replace the original version published in 2011. They address the scope and targets of pharmacological treatment for schizophrenia. A consensus meeting was held in 2017, i...

Cannabidiol as a potential treatment for psychosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843725/
Therapeutic Advances in Psychopharmacology; Davies C,et al

Nov 7th, 2019 - Psychotic disorders such as schizophrenia are heterogeneous and often debilitating conditions that contribute substantially to the global burden of disease. The introduction of dopamine D2 receptor antagonists in the 1950s revolutionised the treat...

U.S. FDA Approves SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the Treatment of Adults with Schizophrenia
http://www.noven.com/PR101519.php

Oct 14th, 2019 - Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Administration (FDA) has approved SECUADO® (asenapine) transdermal system, the first-and-only transdermal patch fo...

see more →

Drugs  1,723 results see all →

Clinicaltrials.gov  71,661 results

Maternal Infection in Gestation and Risk of Mental Disorders in Offspring During Adulthood
https://www.medscape.com/viewarticle/953352

Jun 17th, 2021 - Takeaway Maternal infection during gestation is a risk factor for non-affective psychosis and schizophrenia in the offspring in later life. Why this matters The precise underlying mechanism through which maternal infection contributes to the aetio...

A Community-Based Mental Health Program Pivots During the Pandemic
https://www.medscape.com/viewarticle/953393

Jun 17th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For more than 70 years, Fountain House has offered a lifeline for people living with schizophrenia, bipolar disorder, major depression, and other ...

Aripiprazole - aripiprazole tablet-Camber Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d8d574b-fbf4-4d2c-a37c-25556ecbf1aa

Jun 17th, 2021 - Aripiprazole oral tablets are indicated for the treatment of: • Schizophrenia [see Clinical Studies ( 14.1)] Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc.’s ABILIFY ® (aripiprazole) product. However, due ...

Emerging Schizophrenia Drugs Target Negative Symptoms
https://www.medscape.com/viewarticle/953336

Jun 16th, 2021 - Late-stage trials of new antipsychotic drugs are showing promise in the control of negative symptoms, according to an overview presented by Current Psychiatry and the American Academy of Clinical Psychiatrists. Dr Henry A. Nasrallah The progress i...

Olanzapine - olanzapine tablet, orally disintegrating-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ff9fc66-8367-445b-bb35-f6b112543d36

Jun 15th, 2021 - Olanzapine is an atypical antipsychotic indicated: As oral formulation for the: Treatment of schizophrenia. (1.1) Adults: Efficacy was established in three clinical trials in patients with schizophrenia: two 6-week trials and one maintenance trial...

see more →

News  2,707 results

Maternal Infection in Gestation and Risk of Mental Disorders in Offspring During Adulthood
https://www.medscape.com/viewarticle/953352

Jun 17th, 2021 - Takeaway Maternal infection during gestation is a risk factor for non-affective psychosis and schizophrenia in the offspring in later life. Why this matters The precise underlying mechanism through which maternal infection contributes to the aetio...

A Community-Based Mental Health Program Pivots During the Pandemic
https://www.medscape.com/viewarticle/953393

Jun 17th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For more than 70 years, Fountain House has offered a lifeline for people living with schizophrenia, bipolar disorder, major depression, and other ...

Emerging Schizophrenia Drugs Target Negative Symptoms
https://www.medscape.com/viewarticle/953336

Jun 16th, 2021 - Late-stage trials of new antipsychotic drugs are showing promise in the control of negative symptoms, according to an overview presented by Current Psychiatry and the American Academy of Clinical Psychiatrists. Dr Henry A. Nasrallah The progress i...

Once-Weekly Oral Antipsychotic for Schizophrenia on the Horizon 
https://www.medscape.com/viewarticle/952426

Jun 2nd, 2021 - A novel, ultra-long-acting oral formulation of the antipsychotic risperidone (Risperdal) only needs to be taken once weekly and appears to be safe and effective, results of a new phase 2 study suggest. The new formulation, LYN-005 (Lyndra Therapeu...

Schizophrenia Meds a Key Contributor to Cognitive Impairment
https://www.medscape.com/viewarticle/952412

Jun 2nd, 2021 - Dr Yash Joshi Anticholinergic medication burden from antipsychotics, antidepressants, and other psychotropics has a cumulative effect of worsening cognitive function in patients with schizophrenia, new research indicates. "The link between long-te...

see more →

Patient Education  33 results see all →